Mizuho Securities Reaffirms Their Hold Rating on Pediatrix Medical Group (MD)

Mizuho Securities analyst maintained a Hold rating on Pediatrix Medical Group on February 20. The company’s shares closed last Friday at $18.82.

Claim 50% Off TipRanks Premium

• Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

In addition to Mizuho Securities, Pediatrix Medical Group also received a Hold from TipRanks – Google’s Google Medical – Care Facilities in a report issued on February 20. However, on the same day, TipRanks – DeepSeek reiterated a Buy rating on Pediatrix Medical Group (NYSE: MD).

Based on Pediatrix Medical Group’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $493.77 million and a net profit of $33.68 million. In comparison, last year the company earned a revenue of $502.36 million and had a net profit of $30.48 million

Based on the recent corporate insider activity of 25 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MD in relation to earlier this year. Most recently, in December 2025, Mark Ordan, the CEO of MD sold 23,000.00 shares for a total of $515,430.00.